 |
인쇄하기
취소
|
Cisapride to be nominated as a drug of second choice.
The KFDA decided to prohibit Cisapride to be prescribed as a drug of the first choice and seemed to take a serious consideration of its sales ban according to drug informations regarding the adverse reactions like serious cardiovascular hazards.
The KFDA notified to the drug makers of Cisapride preparations, labelling additional warning clauses "for the following disorders that are not appr...
The KFDA notified to the drug makers of Cisapride preparations, labelling additional warning clauses "for the following disorders that are not appr...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.